GeneDx Holdings Corp. WGS
Nasdaq · stock · Services-Health Services · website · IPO 2020-09-04
GeneDx Holdings Corp. statistics & valuation
Market cap$1.8B
P / S4.2×
P / B5.8×
P / FCF126.1×
Net margin-4.9%
Return on equity-6.8%
FCF margin3.3%
Net cash$50.5M
Net debt / EBITDA-4.2×
Enterprise value USD$1.7B
Earnings yield EBIT/EV-0.7%
Return on capital-3.2%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | 69.7% | 63.6% | 44.4% | -11.4% | -7.8% | 2.2% |
| Operating margin | -3.1% | -7.6% | -89.2% | -284.5% | -210.3% | -134.9% |
| Net margin | -4.9% | -17.1% | -86.8% | -233.9% | -115.6% | -134.6% |
| FCF margin | 3.3% | -11.1% | -91.5% | -139.0% | -94.2% | -65.4% |
| Return on assets | -4.0% | -12.5% | -42.0% | -111.8% | -44.3% | -95.9% |
| Return on equity | -6.8% | -21.3% | -77.1% | -216.4% | -63.2% | 73.1% |
| Debt / equity | 0.18× | 0.23× | 0.25× | 0.04× | 0.03× | -0.06× |
| Current ratio | 2.46 | 3.61 | 3.10 | 1.47 | 4.77 | 2.37 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.